Clover Health Investments, Corp.
CLOVHealthcareNASDAQHealthcare Plans · Last scanned May 30, 2026
Scan Results
Daily timeframeClover Health Investments, Corp. operates in the Healthcare Plans space. Clover Health Investments, Corp. The company carries a $2.10B market cap, placing it firmly in the mid-cap category. provides medicare advantage plans in the United States.
Market Cap
$2.10B
Beta
2.45
P/E (TTM)
—
P/E (Fwd)
39.80
EPS (TTM)
$-0.12
EPS (Fwd)
$0.10
ROE
-16.9%
ROA
-5.5%
Cash
$203.5M
Total Debt
$0
Free CF
$75.1M
52W Change
25.6%
Annual Financials
Cash vs Debt
Clover Health Investments, Corp. reports $203.5M in cash and $0 in total debt. Free cash flow comes in at $75.1M, providing flexibility for reinvestment, buybacks, or dividends. Consistent free cash flow generation is often considered a sign of operational health. ROE of -16.9% points to negative capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. Revenue has grown from $1.10B (2022) to $1.92B (2025), reflecting a 75% increase over the period.
A beta of 2.45 means CLOV is more volatile than average. Investors should be prepared for wider price swings relative to broader indices. It is important to consider these factors alongside broader market conditions and individual financial goals when reviewing CLOV.